Published in Gene Ther on March 01, 2007
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J (2011) 1.67
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci U S A (2009) 1.55
METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. Immunol Endocr Metab Agents Med Chem (2010) 1.50
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve (2009) 1.34
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet (2008) 1.32
Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle (2011) 1.28
Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med (2009) 1.22
Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther (2009) 1.21
Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal (2009) 1.16
Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass. Immunol Endocr Metab Agents Med Chem (2010) 1.13
Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. PLoS One (2010) 1.10
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Hum Mol Genet (2009) 1.09
Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice. Mol Ther (2010) 1.01
Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. Am J Pathol (2011) 0.98
Relation between extent of myostatin depletion and muscle growth in mature mice. Am J Physiol Endocrinol Metab (2009) 0.96
The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy. Genes Dev (2013) 0.94
Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. Am J Pathol (2009) 0.92
Animal models for metabolic, neuromuscular and ophthalmological rare diseases. Nat Rev Drug Discov (2013) 0.92
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice. Acta Myol (2008) 0.87
Novel therapeutic approaches for inclusion body myositis. Curr Opin Rheumatol (2010) 0.85
Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther (2011) 0.85
Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov (2016) 0.82
Ongoing developments in sporadic inclusion body myositis. Curr Rheumatol Rep (2014) 0.78
Caveolin-3 regulates myostatin signaling. Mini-review. Acta Myol (2008) 0.78
Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). Mol Med Rep (2014) 0.78
Myostatin in the pathophysiology of skeletal muscle. Curr Genomics (2007) 0.78
Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies. Neurotherapeutics (2008) 0.77
Adeno-associated virus-mediated expression of myostatin propeptide improves the growth of skeletal muscle and attenuates hyperglycemia in db/db mice. Gene Ther (2016) 0.75
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol (1987) 5.13
A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88
Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science (1997) 4.86
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72
Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol (1992) 4.58
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell (1995) 4.41
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol (1995) 3.04
An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol (1991) 3.04
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol (1983) 2.69
Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol (1995) 2.60
Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.59
Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol (2001) 2.56
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma. J Virol (1985) 2.40
Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci U S A (1985) 2.40
Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res (2000) 2.39
Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet (1995) 2.16
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther (1997) 2.09
Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol (2000) 2.00
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J (2002) 2.00
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med (1999) 1.94
Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet (1993) 1.87
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. II. Nucleotide sequence of the lysA gene and its regulatory region. J Mol Biol (1983) 1.85
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol (1994) 1.83
Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology (2005) 1.77
The health insurance status of US Latino women: A profile from the 1982-1984 HHANES. Am J Public Health (1996) 1.77
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Translating the CAHPS 1.0 Survey Instruments into Spanish. Consumer Assessment of Health Plans Study. Med Care (1999) 1.68
Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med (2001) 1.66
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem (1980) 1.64
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther (2006) 1.61
Randomized, controlled trial comparing the retention of a flowable restorative system with a conventional resin sealant: one-year follow up. Int J Paediatr Dent (2005) 1.57
A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci III (1991) 1.56
N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J Cell Sci (1992) 1.52
One step screening of retroviral producer clones by real time quantitative PCR. J Gene Med (2000) 1.50
Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology (1994) 1.50
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49
Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J Virol (1995) 1.49
Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J Virol (1993) 1.48
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord (1999) 1.45
Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol (1999) 1.44
The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans. Mol Biochem Parasitol (2001) 1.43
Kidney graft survival in patients with hepatitis C: a single center experience. Clin Transplant (2008) 1.41
Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice. J Cell Biol (2000) 1.41
Relationship of pain and ancestry in African American women. Eur J Pain (2015) 1.40
Papillomavirus genomes: sequences and consequences. J Invest Dermatol (1984) 1.38
Cardiopulmonary resuscitation training: in need of some critical care? Br J Anaesth (2005) 1.37
Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem (1998) 1.36
Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval. Am J Hum Genet (1995) 1.34
alpha11beta1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol (2001) 1.32
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol (1999) 1.31
Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). Brain (1998) 1.30
Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg (1977) 1.29
Mini-F encoded proteins: identification of a new 10.5 kilodalton species. EMBO J (1983) 1.29
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther (2006) 1.29
Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology (2001) 1.28
Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain (1996) 1.27
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome. J Med Genet (2002) 1.26
Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol (1998) 1.25
A homeobox gene, vax2, controls the patterning of the eye dorsoventral axis. Proc Natl Acad Sci U S A (1999) 1.24
A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther (2005) 1.24
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet (1987) 1.24
A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 55 polymorphic microsatellites. Hum Mol Genet (1993) 1.23
Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J Physiol (2002) 1.19
Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes. Hum Mol Genet (2000) 1.18
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol (2000) 1.16
Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res (1992) 1.16
Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A (2002) 1.16
Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. Ciba Found Symp (1986) 1.14
How neutral are synonymous codon mutations? Nat Genet (1995) 1.14
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology (2001) 1.13
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol (2001) 1.11
Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A (2001) 1.10
Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet (1997) 1.10
Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol (1998) 1.09
Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia (1995) 1.08
Persistent left superior vena cava complicating pacemaker catheter insertion. Chest (1972) 1.07
Post-traumatic syringomyelia and post-traumatic spinal canal stenosis: a direct relationship: review of 75 patients with a spinal cord injury. Spinal Cord (1998) 1.06
Tetranucleotide repeat polymorphism at the human N-MYC gene (MYCN). Nucleic Acids Res (1992) 1.06
Simultaneous and spontaneous bilateral rupture of the patellar tendon in rheumatoid arthritis. A case report. Acta Orthop Scand (1975) 1.04
Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. AIDS Res Hum Retroviruses (1992) 1.04
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 1.04
Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord (1996) 1.02
Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med (2001) 1.02
Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord (2004) 1.02
Mapping of a chromosome 15 region involved in limb girdle muscular dystrophy. Hum Mol Genet (1994) 1.02
Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood (1993) 1.01